Clinical Trials
2
Active:0
Completed:0
Trial Phases
1 Phases
Phase 2:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (100.0%)Weight-based Dosing in Hemophilia A
Phase 2
Terminated
- Conditions
- Hemophilia
- Interventions
- Drug: rFVIII
- First Posted Date
- 2015-10-26
- Last Posted Date
- 2020-09-25
- Lead Sponsor
- Craig Seaman
- Target Recruit Count
- 30
- Registration Number
- NCT02586012
- Locations
- 🇺🇸
Hemophilia Center of Western Pennsylvania, Pittsburgh, Pennsylvania, United States
Feasibility Study of Unfractionated Heparin in Acute Chest Syndrome
Phase 2
Terminated
- Conditions
- Sickle Cell DiseaseAcute Chest Syndrome
- Interventions
- First Posted Date
- 2014-03-28
- Last Posted Date
- 2019-07-16
- Lead Sponsor
- Craig Seaman
- Target Recruit Count
- 7
- Registration Number
- NCT02098993
- Locations
- 🇺🇸
University of Pittsburg Medical Center, Pittsburgh, Pennsylvania, United States
News
No news found